Is the C34T polymorphism of the AMPD1 gene associated with athlete performance in rowing?

International Journal of Sports Medicine

Volumn 32, Issue 12, 2011, Pages 987-991

  Ciȩszczyk, Pawe ^a   Eider, J ^a   Ostanek, M ^b   Leoska Duniec, A ^a   Ficek, K ^c   Kotarska, K ^a   Girdauskas, G ^d  

^a UNIVERSITY OF SZCZECIN   (Poland)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

^c Galen Medical Center   (Poland)

^d LITHUANIAN SPORTS UNIVERSITY   (Lithuania)

Author keywords

AMPD; athlete performance; genotype; rowing

Indexed keywords

ADENOSINE MONOPHOSPHATE DEAMINASE; AMPD1 PROTEIN, HUMAN;

ADULT; ARTICLE; ATHLETIC PERFORMANCE; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SHIP; SKELETAL MUSCLE; SPORT; STATISTICS; TASK PERFORMANCE;

ADULT; AMP DEAMINASE; ATHLETIC PERFORMANCE; CHI-SQUARE DISTRIBUTION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; POLYMORPHISM, GENETIC; SHIPS; SPORTS; STATISTICS AS TOPIC; TASK PERFORMANCE AND ANALYSIS; YOUNG ADULT;

EID: 82655187111     PISSN: 01724622     EISSN: 14393964     Source Type: Journal    
DOI: 10.1055/s-0031-1283186     Document Type: Article

References (36)

1. Ahmetov I I, Williams A G, Popov D V, Lyubaeva E V, Hakimullina A M, Fedotovskaya O N, Mozhayskaya I A, Vinogradova O L, Astratenkova I V, Montgomery H E, Rogozkin V A. The combined impact of metabolic gene polymorphisms on elite endurance athlete status and related phenotypes. Hum Genet: 2009; 126 751 761
2. Broberg S, Sahlin K. Adenine nucleotide degradation in human skeletal muscle during prolonged exercise. J Appl Physiol: 1989; 67 116 122 (Pubitemid 19196456)
3. Cooke R, Pate E. The effects of ADP and phosphate on the contraction of muscle fibers. Biophys J: 1985; 48 789 98 (Pubitemid 16234576)
4. De Ruiter C J, May A M, van Engelen B G, Wevers R A, Steenbergen-Spanjers G C, de Haan A. Muscle function during repetitive moderate-intensity muscle contractions in myoadenylate deaminase-deficient Dutch subjects. Clin Sci: 2002; 102 531 539 (Pubitemid 34494194)
5. Dudley G A, Staron R S, Murray T F, Hagerman F C, Luginbuhl A. Muscle fiber composition and blood ammonia levels after intense exercise in humans. J Appl Physiol: 1983; 54 582 586 (Pubitemid 13153542)
6. Eynon N, Meckel Y, Alves A J, Nemet D, Eliakim D. Is there an interaction between BDKRB29/+9 and GNB3 C825T polymorphisms and elite athletic performance? Scand J Med Sci Sports: 2011; Jan 7 10.1111/j.1600-0838.2010.01261.x. [Epub ahead of print]
7. Fishbein W N, Armbrustmacher V W, Griffin J L. Myoadenylate deaminase deficiency: a new disease of muscle. Science: 1978; 200 545 548 (Pubitemid 8328387)
8. Fishbein W N, Foellmer J W, Davis J I. Medical implications of the lactate and ammonia relationship in anaerobic exercise. Int J Sports Med: 1990; 11 91 100
9. Fischer H, Esbjornsson M, Sabina R L, Stromberg A, Peyrard-Janvid M, Norman B. AMP deaminase deficiency is associated with lower sprint cycling performance in healthy subjects. J Appl Physiol: 2007; 103 315 322 (Pubitemid 47092306)
10. Gross M. Molecular biology of AMP deaminase deficiency. Pharm World Sci: 1994; 16 55 61 (Pubitemid 24142447)
11. Gross M. Clinical heterogeneity and molecular mechanisms in inborn muscle AMP deaminase deficiency. J Inherit Metab Dis: 1997; 20 186 192 (Pubitemid 27273482)
12. Harriss D J, Atkinson G. Update Ethical Standards in Sport and Exercise Science Research. Int J Sports Med: 2011; 32 819 821
13. Lowenstein J M. The purine nucleotide cycle revised. Int J Sports Med: 1990; 11 37 46
14. Lucia A, Martin M A, Esteve-Lanao J, San Juan A F, Rubio J C, Olivn J, Arenas J. C34T mutation of the AMPD1 gene in an elite white runner. Br J Sports Med: 2006; 40 e7
15. Meckel Y, Nemet D, Alves A J, Eliakim A, Eynon N. AMPD1 C34T Mutation is not associated with the status of Israeli athletes. Eur J Sport Sci. [in press]
16. Morisaki T, Gross M, Morisaki H, Pongratz D, Zllner N, Holmes E W. Molecular basis of AMP deaminase deficiency in skeletal muscle. Proc Natl Acad Sci USA: 1992; 89 6457 6461
17. Morisaki T, Sabina R L, Holmes E W. Adenylate deaminase. A multigene family in humans and rats. J Biol Chem: 1990; 265 11482 11486
18. Muniesa C A, Gonzalez-Freire M, Santiago C, Lao J I, Buxens A, Rubio J C, Martin M A, Arenas J, Gomez-Gallego F, Lucia A. World-class performance in lightweight rowing: is it genetically influenced? A comparison with cyclists, runners and non-athletes. Br J Sports Med: 2008; 44 898 901
19. Norman B, Mahnke-Zizelman D K, Vallis A, Sabina R L. Genetic and other determinants of AMP deaminase activity in healthy adult skeletal muscle. J Appl Physiol: 1998; 85 1273 1278 (Pubitemid 28465052)
20. Norman B, Sollevi A, Jansson E. Increased IMP content in glycogen-depleted muscle fibres during submaximal exercise in man. ActaPhysiol Scand: 1988; 133 97 100
21. Rico-Sanz J, Rankinen T, Joanisse D R, Leon A S, Skinner J S, Wilmore J H, Rao D C, Bouchard C. Associations between cardiorespiratory responses to exercise and the C34T AMPD1 gene polymorphism in the HERITAGE Family study. Physiol Genomics: 2003; 14 161 166 (Pubitemid 37345224)
22. Rubio J C, Martn M A, Rabadan M, Leon A S, Skinner J S, Wilmore J H, Rao D C, Bouchard C. Frequency of the C34T mutation of the AMPD1 gene in world-class endurance athletes: does this mutation impair performance? J Appl Physiol: 2005; 98 2108 2112 (Pubitemid 40726903)
23. Rubio J C, Prez M, Mat-Muoz J L, Garca-Consuegra I, Chamorro-Via C, Fernndez del Valle M, Andreu A L, Martn M A, Arenas J, Lucia A. AMPD1 genotypes and exercise capacity in McArdle patients. Int J Sports Med: 2008; 29 331 335 (Pubitemid 351542895)
24. Sabina R L, Holmes E W. Myoadenylate deaminase deficiency. In: Scriver C R, Beaudet A L, Sly W S, Vale D. (eds) The Metabolic and Molecular Basis of Inherited Disease. New York McGraw-Hill: 2001; 2627 2638
25. Sabina R L, Morisaki T, Clarke P, Eddy R, Shows T B, Morton C C, Holmes E W. Characterization of the human and rat myoadenylate deaminase genes. J Biol Chem: 1990; 265 9423 9433
26. Sabina R L, Swain J L, Olanow C W, Bradley W G, Fishbein W N, DiMauro S, Holmes E W. Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle. J Clin Invest: 1984; 73 720 730 (Pubitemid 14156854)
27. Safronow K, Czyzycka E, Binczak-Kuleta A, Rzeuski R, Skowronek J, Wojtarowicz A, Jakubowska K, Olszewska M, Loniewska B, Kaliszczak R, Kornacewicz-Jach Z, Ciechanowicz A, Chlubek D. Association of C34T AMPD1 gene polymorphism with features of patients with coronary artery disease or heart failure. Scand J Clin Lab Investig: 2009; 69 102 112
28. Safranow K, Suchy J, Jakubowska K, Olszewska M, Biczak-Kuleta A, Kurzawski G, Rzeuski R, Czyycka E, oniewska B, Kornacewicz-Jach Z, Ciechanowicz A, Chlubek D. AMPD1 gene mutations are associated with obesity and diabetes in Polish patients with cardiovascular diseases. J Appl Genetics: 2011; 52 67 76
29. Sahlin K, Katz A, Broberg S. Tricarboxylic acid cycle intermediates in human muscle during prolonged exercise. Am J Physiol Cell Physiol: 1990; 259 834 841
30. Santiago C J, Ruiz R, Muniesal C A, Gonzalez-Freire M, Gomez-Gallego F, Lucial A. Does the polygenic profile determine the potential for becoming a world-class athlete? Insights from the sport of rowing. Scand J Med Sci Sports: 2010; 20 e188 e194
31. Secher N H. Physiological and biomechanical aspects of rowing. Implications for training. Sports Med: 1993; 15 24 42 (Pubitemid 23060515)
32. Sinkeler S P, Binkhorst R A, Joosten E M, Wevers R A, Coerwinkei M M, Oei T L. AMP deaminase deficiency: study of the human skeletal muscle purine metabolism during ischemic isometric exercise. Clin Science: 1987; 72 475 482 (Pubitemid 17022699)
33. Spencer M K, Yan Z, Katz A. Effect of low glycogen on carbohydrate and energy metabolism in human muscle during exercise. Am J Physiol Cell Physiol: 1992; 262 975 979
34. Tarnopolsky M A, Parise G, Gibala M J, Graham T E, Rush JW E. Myoadenylate deaminase deficiency does not affect muscle anaplerosis during exhaustive exercise in humans. J Physiol: 2001; 533 881 889 (Pubitemid 32600541)
35. Verzijl H T, van Engelen B G, Luyten J A, Steenbergen G C, van den Heuvel L P, ter Laak H J, Padberg G W, Wevers R A. Genetic characteristics of myoadenylate deaminase deficiency. Ann Neurol: 1998; 44 140 143 (Pubitemid 28323667)
36. Westerblad H, Dahlstedt A J, Lannergren J. Mechanisms underlying reduced maximum shortening velocity during fatigue of intact, single fibers of mouse muscle. J Physiol: 1998; 510 269 277 (Pubitemid 28351941)